434 related articles for article (PubMed ID: 12634796)
1. Disease proteomics.
Hanash S
Nature; 2003 Mar; 422(6928):226-32. PubMed ID: 12634796
[TBL] [Abstract][Full Text] [Related]
2. Application of proteomic technologies to tumor analysis.
Misek DE; Imafuku Y; Hanash SM
Pharmacogenomics; 2004 Dec; 5(8):1129-37. PubMed ID: 15584879
[TBL] [Abstract][Full Text] [Related]
3. Disease proteomics toward bedside reality.
Nishimura T; Ogiwara A; Fujii K; Kawakami T; Kawamura T; Anyouji H; Kato H
J Gastroenterol; 2005 Mar; 40 Suppl 16():7-13. PubMed ID: 15902957
[TBL] [Abstract][Full Text] [Related]
4. Cancer proteomics.
Tan HT; Lee YH; Chung MC
Mass Spectrom Rev; 2012; 31(5):583-605. PubMed ID: 22422534
[TBL] [Abstract][Full Text] [Related]
5. Molecular profiling of human cancer: new opportunities.
Englert CR; Petricoin EF; Krizman DB; Emmert-Buck MR
Curr Opin Mol Ther; 1999 Dec; 1(6):712-9. PubMed ID: 19629868
[TBL] [Abstract][Full Text] [Related]
6. Towards a comprehensive understanding of Bacillus subtilis cell physiology by physiological proteomics.
Hecker M; Völker U
Proteomics; 2004 Dec; 4(12):3727-50. PubMed ID: 15540212
[TBL] [Abstract][Full Text] [Related]
7. Biomarker discovery using molecular profiling approaches.
Walker SJ; Xu A
Int Rev Neurobiol; 2004; 61():1-30. PubMed ID: 15482809
[No Abstract] [Full Text] [Related]
8. Identification of novel targets for cancer therapy using expression proteomics.
Hanash SM; Madoz-Gurpide J; Misek DE
Leukemia; 2002 Apr; 16(4):478-85. PubMed ID: 11960325
[TBL] [Abstract][Full Text] [Related]
9. Application of proteomics in cancer gene profiling: two-dimensional difference in gel electrophoresis (2D-DIGE).
Hariharan D; Weeks ME; Crnogorac-Jurcevic T
Methods Mol Biol; 2010; 576():197-211. PubMed ID: 19882264
[TBL] [Abstract][Full Text] [Related]
10. Gene arrays and proteomics. A primer.
Moulédous L; Gutstein HB
Methods Mol Med; 2003; 84():141-54. PubMed ID: 12703322
[No Abstract] [Full Text] [Related]
11. Gene expression profiling: monitoring transcription and translation products using DNA microarrays and proteomics.
Celis JE; Kruhøffer M; Gromova I; Frederiksen C; Ostergaard M; Thykjaer T; Gromov P; Yu J; Pálsdóttir H; Magnusson N; Orntoft TF
FEBS Lett; 2000 Aug; 480(1):2-16. PubMed ID: 10967322
[TBL] [Abstract][Full Text] [Related]
12. High-throughput proteomics using antibody microarrays.
Wingren C; Borrebaeck CA
Expert Rev Proteomics; 2004 Oct; 1(3):355-64. PubMed ID: 15966831
[TBL] [Abstract][Full Text] [Related]
13. All about DIGE: quantification technology for differential-display 2D-gel proteomics.
Lilley KS; Friedman DB
Expert Rev Proteomics; 2004 Dec; 1(4):401-9. PubMed ID: 15966837
[TBL] [Abstract][Full Text] [Related]
14. The molecular make-up of a tumour: proteomics in cancer research.
Kolch W; Mischak H; Pitt AR
Clin Sci (Lond); 2005 May; 108(5):369-83. PubMed ID: 15831087
[TBL] [Abstract][Full Text] [Related]
15. Microarrays--chances and challenges.
Pilarsky CP; Schmitt AO; Dahl E; Rosenthal A
Curr Opin Mol Ther; 1999 Dec; 1(6):727-36. PubMed ID: 19629870
[TBL] [Abstract][Full Text] [Related]
16. Impact of replicate types on proteomic expression analysis.
Karp NA; Spencer M; Lindsay H; O'Dell K; Lilley KS
J Proteome Res; 2005; 4(5):1867-71. PubMed ID: 16212444
[TBL] [Abstract][Full Text] [Related]
17. Methodologies to decipher the cell secretome.
Mukherjee P; Mani S
Biochim Biophys Acta; 2013 Nov; 1834(11):2226-32. PubMed ID: 23376189
[TBL] [Abstract][Full Text] [Related]
18. Approaches to proteomic analysis of human tumors.
Ahram M; Emmert-Buck MR
Methods Mol Biol; 2003; 222():375-84. PubMed ID: 12710699
[TBL] [Abstract][Full Text] [Related]
19. Approaches for systematic proteome exploration.
Falk R; Ramström M; Ståhl S; Hober S
Biomol Eng; 2007 Jun; 24(2):155-68. PubMed ID: 17376740
[TBL] [Abstract][Full Text] [Related]
20. Exon level integration of proteomics and microarray data.
Bitton DA; Okoniewski MJ; Connolly Y; Miller CJ
BMC Bioinformatics; 2008 Feb; 9():118. PubMed ID: 18298841
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
